Objectives: Treatment modalities for benign pigmented lesions range from cryotherapy to laser and energy-based technologies. These treatments have been shown to be effective, yet may lead to dyschromia or significant downtime. We report a novel Cooling System that provides localized and controlled freezing to benign pigmented lesions.
Introduction: Existing therapeutic modalities for treatment of benign pigmented lesions suffer certain limitations, including risks of post-inflammatory hyperpigmentation especially in susceptible ethnic populations and darker Fitzpatrick skin types. Prior experience with cutaneous cryotherapy has demonstrated the cold sensitivity of melanocytes. A novel device has been developed to deliver precise, controlled, localized cooling to effect a reduction in pigmentation without collateral damage to the epidermis. A GLP animal study was performed to evaluate the dosimetry and role of controlled skin cooling
Materials / method: Preclinical testing was performed in a porcine model. Two female Sinclair Yucatan pigs were treated on the flanks using the Dermal Cooling System. Different contact cooling applicators were used to deliver a range of temperatures and exposure times. Pigmentation changes were assessed by photographic review scoring, and biopsy samples were taken immediately following treatment and monthly thereafter for histopathology. Subsequently, clinical utilization of the Dermal Cooling System was initiated to assess the safety and effectiveness of the device and to evaluate treatment parameter ranges.
Results: In the GLP porcine study, specific exposure conditions were determined that consistently and safely elicited a reduction in pigmentation based on the photographic review. There was an absence of any notable side effects in the animals. Histologic evaluation revealed that localized epidermal cooling was associated with decreases in histomorphometric and histomorphologic pigmentation parameters without adverse tissue reactions. Clinical experience with the device is ongoing. Subjects with lentigines, seborrheic keratosis, melasma, or other hyperpigmentation conditions have been treated
Conclusion: Preclinical and clinical testing have demonstrated the ability to selectively and safely reduce pigmentation using controlled, localized cooling of the epidermis. The Dermal Cooling System provides an alternative to energy-delivery devices for treatment of benign pigmented lesions, offering minimal procedural discomfort and downtime, low risk of post-inflammatory hyperpigmentation, and the ability to treat all skin types.
利益冲突声明
您有否接受任何资金来支持研究这个主题?
否
您是否接受过关于这项研究的任何酬金或其他报酬?
是
请注明名称(个人,公司,学会等等): R2 Dermatology
你是否和任何与您的研究所涉及的药物,材料或工具有密切联系的实体存在财务关系?
否
你是否拥有或者您已经为您此研究中的工具,药物或材料申请任何专利?
否
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。